MAGI2‐AS3 also exerts effects on the biological activities of hepatic cancer cells (Jiang et al., 2016), but the effects and mechanisms of MAGI2‐AS3 in HCC treatment are still unclear. The gene discussed is MAGI2; the disease is hepatocellular carcinoma.